← Leaderboards
Isabella Reichardt
University Of Washington
$128,021
Attributed
$128,021
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.8K · FY2022–24$50K$37.5K$25K$12.5K$0
'22
'23
'24
Funding mix
By agency
NIH$128,021 · 1
By mechanism
F31$128,021 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Geraldine Dawson$27,808,744
- Michael Regnier$25,128,583
- Craig Lewis Duvall$15,130,944
- Stephen R Dager$7,709,318
- Charles E Murry$34,391,211
Others in their field
Other Rising Stars on “Doxycycline”
- Laurene Wang · Aimmax Therapeutics, Inc.$3,356,811
- Stella Coker Watson Self · University Of South Carolina At Columbia$2,240,192
- Nicholas Pannunzio · University Of California-Irvine$1,966,363
- Susana Isabel M M A Da Silva · University Of Pittsburgh At Pittsburgh$1,577,955
- Ekrem Emrah Er · University Of Illinois At Chicago$1,423,178
- Daria Lizneva · Icahn School Of Medicine At Mount Sinai$1,362,850
Research focus
DoxycyclineEfracAtac-SeqAftercareEffective TherapyCardiologyCardiovascular DiseasesCardiovascular SystemCareerCardiacCellsChromatinChromatin RemodelingClinically RelevantCollagenCongestive Heart FailureCoupledCytoskeletonDepositionDilated CardiomyopathyCareer DevelopmentDna MethylationDoseEngineering
Grant awards (3)
Investigating the Time-Dependent Reversibility of DCM-Induced Epigenetic, Matrix, and Functional Remodeling$43,841
F31 · FY2024 · HL · contact PI
Investigating the Time-Dependent Reversibility of DCM-Induced Epigenetic, Matrix, and Functional Remodeling$42,561
F31 · FY2023 · HL · contact PI
Investigating the Time-Dependent Reversibility of DCM-Induced Epigenetic, Matrix, and Functional Remodeling$41,619
F31 · FY2022 · HL · contact PI